Back
ZyVersa Therapeutics Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
ZVSA
ZyVersa Therapeutics
Last Price:
$0.80
Seasonality Move:
-46.45%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and ZVSA is experiencing selling pressure, which indicates risk of future bearish movement.
ZyVersa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Buy |
| 20-day SMA: | 0.74 | Buy |
| 50-day SMA: | 1 | Sell |
| 200-day SMA: | 2 | Sell |
| 8-day EMA: | 0.82 | Sell |
| 20-day EMA: | 0.8 | Sell |
| 50-day EMA: | 0.95 | Sell |
| 200-day EMA: | 17.44 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 48.22 | Sell |
| Chaikin Money Flow: | -5388556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.93) | Buy |
| Bollinger Bands (100): | (0.85 - 1.33) | Sell |
ZyVersa Therapeutics Technical Analysis
| Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.78 while ZVSA 8-day simple moving average is 0.76, which is a Buy signal.
-
The stock price of ZVSA is 0.78 while ZyVersa Therapeutics 20-day SMA is 0.74, which makes it a Buy.
-
ZyVersa Therapeutics 50-day simple moving average is 1.00 while ZVSA share price is 0.78, making it a Sell technically.
-
ZVSA stock price is 0.78 and ZyVersa Therapeutics 200-day simple moving average is 2.00, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
18
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.78. The Score for ZVSA is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
2M
Price in USD:
0.78
Share Volume:
5.4M
ZyVersa Therapeutics 52-Week Range
52-Week High:
8.05
52-Week Low:
0.55
Sell
18
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.78 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.78 while ZVSA 8-day exponential moving average is 0.82, which is a Sell signal.
-
The stock price of ZVSA is 0.78 while ZyVersa Therapeutics 20-day EMA is 0.80, which makes it a Sell.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.95 while ZVSA share price is 0.78, making it a Sell technically.
-
ZVSA stock price is 0.78 and ZyVersa Therapeutics 200-day simple moving average is 17.44, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting ZyVersa Therapeutics is a Sell
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 48.22, which suggest ZyVersa Therapeutics is oversold
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (0.61 - 0.93), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (0.85 - 1.33), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.